137 related articles for article (PubMed ID: 25614175)
21. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
22. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
Stockley RA; Edgar RG; Pillai A; Turner AM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary abnormalities and carotid atherosclerosis in ex-smokers without airflow limitation.
Pike D; Kirby M; Lindenmaier TJ; Sheikh K; Neron CE; Hackam DG; Spence JD; Fenster A; Paterson NA; Sin DD; Coxson HO; McCormack DG; Parraga G
COPD; 2015 Feb; 12(1):62-70. PubMed ID: 24921977
[TBL] [Abstract][Full Text] [Related]
24. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease.
Drummond MB; Hansel NN; Connett JE; Scanlon PD; Tashkin DP; Wise RA
Am J Respir Crit Care Med; 2012 Jun; 185(12):1301-6. PubMed ID: 22561963
[TBL] [Abstract][Full Text] [Related]
25. Bronchodilator response of advanced lung function parameters depending on COPD severity.
Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
[TBL] [Abstract][Full Text] [Related]
26. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
[TBL] [Abstract][Full Text] [Related]
27. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers.
Hao W; Li M; Zhang Y; Zhang C; Wang P
Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary Artery Abnormalities in Ex-smokers with and without Airflow Obstruction.
Lindenmaier TJ; Kirby M; Paulin G; Mielniczuk L; Cunningham IA; Mura M; Licskai C; Parraga G
COPD; 2016; 13(2):224-34. PubMed ID: 26606693
[TBL] [Abstract][Full Text] [Related]
29. Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.
Husebø GR; Grønseth R; Lerner L; Gyuris J; Hardie JA; Bakke PS; Eagan TM
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28298399
[TBL] [Abstract][Full Text] [Related]
30. Decline in FEV
Hiller AM; Piitulainen E; Jehpsson L; Tanash H
Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
[No Abstract] [Full Text] [Related]
31. Pulmonary surfactant-associated protein B regulates prostaglandin-endoperoxide synthase-2 and inflammation in chronic obstructive pulmonary disease.
Wang Y; Gao X; Li Y; Wang X; Li Y; Zhang S; Liu H; Guo H; Lu W; Sun D
Exp Physiol; 2021 May; 106(5):1303-1311. PubMed ID: 33729612
[TBL] [Abstract][Full Text] [Related]
32. Chronic respiratory symptoms, von Willebrand factor and longitudinal decline in FEV1.
Chambers DC; Boldy DA; Ayres JG
Respir Med; 1999 Oct; 93(10):726-33. PubMed ID: 10581662
[TBL] [Abstract][Full Text] [Related]
33. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
[TBL] [Abstract][Full Text] [Related]
34. Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation.
Mohamed Hoesein FA; de Jong PA; Lammers JW; Mali WP; Schmidt M; de Koning HJ; van der Aalst C; Oudkerk M; Vliegenthart R; Groen HJ; van Ginneken B; van Rikxoort EM; Zanen P
Eur Respir J; 2015 Mar; 45(3):644-51. PubMed ID: 25614166
[TBL] [Abstract][Full Text] [Related]
35. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Gan WQ; Man SF; Postma DS; Camp P; Sin DD
Respir Res; 2006 Mar; 7(1):52. PubMed ID: 16571126
[TBL] [Abstract][Full Text] [Related]
36. Can high resolution computed tomography predict lung function in patients with chronic obstructive pulmonary disease?
Spiropoulos K; Trakada G; Kalamboka D; Kalogeropoulou C; Petsas T; Efremidis G; Tsiamita M; Trakada A; Dimopoulos I
Lung; 2003; 181(4):169-81. PubMed ID: 14692557
[TBL] [Abstract][Full Text] [Related]
37. Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers.
Mesia-Vela S; Yeh CC; Austin JH; Dounel M; Powell CA; Reeves A; Santella RM; Stevenson L; Yankelevitz D; Barr RG
Biomarkers; 2008 Jun; 13(4):422-34. PubMed ID: 18484356
[TBL] [Abstract][Full Text] [Related]
38. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
[TBL] [Abstract][Full Text] [Related]
39. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
[TBL] [Abstract][Full Text] [Related]
40. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.
Nishimura M; Makita H; Nagai K; Konno S; Nasuhara Y; Hasegawa M; Shimizu K; Betsuyaku T; Ito YM; Fuke S; Igarashi T; Akiyama Y; Ogura S;
Am J Respir Crit Care Med; 2012 Jan; 185(1):44-52. PubMed ID: 22016444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
